1. Home
  2. NABL vs BHVN Comparison

NABL vs BHVN Comparison

Compare NABL & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$7.60

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.54

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
BHVN
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NABL
BHVN
Price
$7.60
$11.54
Analyst Decision
Buy
Buy
Analyst Count
4
16
Target Price
$9.31
$29.79
AVG Volume (30 Days)
848.8K
3.5M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$497,665,000.00
N/A
Revenue This Year
$11.18
N/A
Revenue Next Year
$8.73
$2,219.74
P/E Ratio
N/A
N/A
Revenue Growth
8.65
N/A
52 Week Low
$6.07
$7.48
52 Week High
$10.41
$44.28

Technical Indicators

Market Signals
Indicator
NABL
BHVN
Relative Strength Index (RSI) 52.50 57.02
Support Level $7.49 $8.29
Resistance Level $7.74 $11.71
Average True Range (ATR) 0.19 0.72
MACD 0.06 0.47
Stochastic Oscillator 79.23 95.32

Price Performance

Historical Comparison
NABL
BHVN

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: